Michael Ryskin
Stock Analyst at B of A Securities
(1.88)
# 3,263
Out of 5,113 analysts
39
Total ratings
52%
Success rate
0.14%
Average return
Main Sectors:
Stocks Rated by Michael Ryskin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SDGR Schrödinger | Upgrades: Buy | $24 | $14.88 | +61.29% | 3 | Dec 15, 2025 | |
| RVTY Revvity | Maintains: Buy | $110 → $99 | $114.61 | -13.62% | 1 | Sep 22, 2025 | |
| TEM Tempus AI | Maintains: Neutral | $68 → $70 | $66.81 | +4.77% | 6 | Jun 25, 2025 | |
| IDXX IDEXX Laboratories | Maintains: Neutral | $535 → $475 | $694.75 | -31.63% | 3 | Apr 21, 2025 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Buy | $9 → $8 | $3.80 | +110.80% | 3 | Mar 3, 2025 | |
| ALGN Align Technology | Maintains: Underperform | $200 → $206 | $167.04 | +23.32% | 6 | Dec 13, 2024 | |
| GH Guardant Health | Maintains: Buy | $28 → $40 | $114.59 | -65.09% | 1 | Jul 18, 2024 | |
| ALIT Alight | Maintains: Buy | $10 → $9.5 | $1.61 | +490.06% | 1 | Jun 25, 2024 | |
| CERT Certara | Maintains: Buy | $27 → $24 | $9.68 | +147.93% | 2 | Aug 15, 2023 | |
| AVTR Avantor | Maintains: Buy | $27 → $24 | $11.65 | +106.01% | 2 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $225 → $180 | $124.96 | +44.05% | 7 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.60 | - | 2 | Apr 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $17 → $10 | $2.98 | +235.57% | 2 | Nov 10, 2021 |
Schrödinger
Dec 15, 2025
Upgrades: Buy
Price Target: $24
Current: $14.88
Upside: +61.29%
Revvity
Sep 22, 2025
Maintains: Buy
Price Target: $110 → $99
Current: $114.61
Upside: -13.62%
Tempus AI
Jun 25, 2025
Maintains: Neutral
Price Target: $68 → $70
Current: $66.81
Upside: +4.77%
IDEXX Laboratories
Apr 21, 2025
Maintains: Neutral
Price Target: $535 → $475
Current: $694.75
Upside: -31.63%
Maravai LifeSciences Holdings
Mar 3, 2025
Maintains: Buy
Price Target: $9 → $8
Current: $3.80
Upside: +110.80%
Align Technology
Dec 13, 2024
Maintains: Underperform
Price Target: $200 → $206
Current: $167.04
Upside: +23.32%
Guardant Health
Jul 18, 2024
Maintains: Buy
Price Target: $28 → $40
Current: $114.59
Upside: -65.09%
Alight
Jun 25, 2024
Maintains: Buy
Price Target: $10 → $9.5
Current: $1.61
Upside: +490.06%
Certara
Aug 15, 2023
Maintains: Buy
Price Target: $27 → $24
Current: $9.68
Upside: +147.93%
Avantor
Jul 31, 2023
Maintains: Buy
Price Target: $27 → $24
Current: $11.65
Upside: +106.01%
Nov 4, 2022
Maintains: Buy
Price Target: $225 → $180
Current: $124.96
Upside: +44.05%
Apr 18, 2022
Downgrades: Neutral
Price Target: n/a
Current: $4.60
Upside: -
Nov 10, 2021
Downgrades: Underperform
Price Target: $17 → $10
Current: $2.98
Upside: +235.57%